Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
Plugging Immune Cell Leakage from Tumors Could Improve Skin Cancer Treatment
The number of specialized immune cells available for fighting skin cancer doubled when a new […]
Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseq™) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment
Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]
Researchers Discover New Model for "Global" DNA Repair
Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]
NYU Langone Health Launches Parekh Center for Interdisciplinary Neurology to Accelerate Scientific Discovery
NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible […]
Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging
A computer program trained to see patterns among thousands of breast ultrasound images can aid […]
FDA Clears NYU Langone Genome PACT
The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]
New Class of Compounds Found to Block Coronavirus Reproduction
A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help […]
Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers
Early results show that a new combination drug therapy is safe and effective against advanced […]
- Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
- Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
- BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
- Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
- GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more